By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences has amended a licensing deal with Arizona Technology Enterprise to include the rights to sequencing-based detection methods that do not rely on optically-labeled nucleotides, the Cambridge, Mass.-based firm announced after the close of the market on Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.